Cue Biopharma Inc P/E
Cos'è P/E di Cue Biopharma Inc?
P/E di Cue Biopharma Inc è N/A
Qual è la definizione di P/E?
Il rapporto prezzo / utili è il rapporto tra il prezzo delle azioni di una società e l'utile per azione della società calcolato su dodici mesi.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E di aziende nel Health Care settore su NASDAQ rispetto a Cue Biopharma Inc
Cosa fa Cue Biopharma Inc?
cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci
Aziende con p/e simili a Cue Biopharma Inc
- Golden Arrow Resources ha P/E di N/A
- Easun Reyrolle ha P/E di N/A
- Seres Therapeutics Inc ha P/E di N/A
- ARSS Infrastructure Projects ha P/E di N/A
- Altisource Portfolio Solutions S.A ha P/E di N/A
- Wealth Glory ha P/E di N/A
- Cue Biopharma Inc ha P/E di N/A
- New Western ha P/E di N/A
- Egr Exploration Ltd ha P/E di N/A
- Gemini Investments () ha P/E di N/A
- Tectonic Metals ha P/E di N/A
- Emergent Biosolutions Inc ha P/E di N/A
- Jaxsta ha P/E di N/A